Logo image of INLX

INTELLINETICS INC (INLX) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:INLX - US45825X2045 - Common Stock

8.25 USD
-0.21 (-2.48%)
Last: 12/15/2025, 8:04:00 PM
Fundamental Rating

3

INLX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. The financial health of INLX is average, but there are quite some concerns on its profitability. INLX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

INLX had negative earnings in the past year.
INLX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INLX reported negative net income in multiple years.
INLX had a positive operating cash flow in each of the past 5 years.
INLX Yearly Net Income VS EBIT VS OCF VS FCFINLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

With a Return On Assets value of -10.15%, INLX is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
The Return On Equity of INLX (-15.06%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -10.15%
ROE -15.06%
ROIC N/A
ROA(3y)-0.03%
ROA(5y)-2%
ROE(3y)0.16%
ROE(5y)-27.83%
ROIC(3y)N/A
ROIC(5y)N/A
INLX Yearly ROA, ROE, ROICINLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

Looking at the Gross Margin, with a value of 65.50%, INLX is in line with its industry, outperforming 45.36% of the companies in the same industry.
In the last couple of years the Gross Margin of INLX has declined.
The Profit Margin and Operating Margin are not available for INLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y-3.79%
INLX Yearly Profit, Operating, Gross MarginsINLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

4

2. Health

2.1 Basic Checks

INLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INLX has been increased compared to 1 year ago.
INLX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for INLX has been reduced compared to a year ago.
INLX Yearly Shares OutstandingINLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
INLX Yearly Total Debt VS Total AssetsINLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

INLX has an Altman-Z score of 2.90. This is not the best score and indicates that INLX is in the grey zone with still only limited risk for bankruptcy at the moment.
INLX's Altman-Z score of 2.90 is in line compared to the rest of the industry. INLX outperforms 57.86% of its industry peers.
INLX has a debt to FCF ratio of 0.16. This is a very positive value and a sign of high solvency as it would only need 0.16 years to pay back of all of its debts.
INLX has a Debt to FCF ratio of 0.16. This is amongst the best in the industry. INLX outperforms 80.36% of its industry peers.
INLX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
INLX's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. INLX outperforms 64.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.16
Altman-Z 2.9
ROIC/WACCN/A
WACC11.16%
INLX Yearly LT Debt VS Equity VS FCFINLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

INLX has a Current Ratio of 0.98. This is a bad value and indicates that INLX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.98, INLX is not doing good in the industry: 75.36% of the companies in the same industry are doing better.
A Quick Ratio of 0.95 indicates that INLX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.95, INLX is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.95
INLX Yearly Current Assets VS Current LiabilitesINLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

3

3. Growth

3.1 Past

INLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -290.00%.
The Revenue has been growing slightly by 6.70% in the past year.
INLX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.02% yearly.
EPS 1Y (TTM)-290%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.11%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y16.28%
Revenue growth 5Y48.02%
Sales Q2Q%-12.82%

3.2 Future

Based on estimates for the next years, INLX will show a very negative growth in Earnings Per Share. The EPS will decrease by -57.00% on average per year.
Based on estimates for the next years, INLX will show a small growth in Revenue. The Revenue will grow by 2.92% on average per year.
EPS Next Y-325%
EPS Next 2Y-57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-8.55%
Revenue Next 2Y2.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INLX Yearly Revenue VS EstimatesINLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
INLX Yearly EPS VS EstimatesINLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INLX. In the last year negative earnings were reported.
Also next year INLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INLX Price Earnings VS Forward Price EarningsINLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

INLX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. INLX is cheaper than 73.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.36
EV/EBITDA N/A
INLX Per share dataINLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as INLX's earnings are expected to decrease with -57.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-57%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for INLX!.
Industry RankSector Rank
Dividend Yield 0%

INTELLINETICS INC

NYSEARCA:INLX (12/15/2025, 8:04:00 PM)

8.25

-0.21 (-2.48%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-23 2026-03-23/amc
Inst Owners7.99%
Inst Owner Change6.21%
Ins Owners27.64%
Ins Owner Change0.43%
Market Cap36.96M
Revenue(TTM)18.02M
Net Income(TTM)-1.74M
Analysts82.86
Price Target14.79 (79.27%)
Short Float %0.02%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-32.42%
Min EPS beat(2)-85.19%
Max EPS beat(2)20.34%
EPS beat(4)2
Avg EPS beat(4)-239.86%
Min EPS beat(4)-982.35%
Max EPS beat(4)87.75%
EPS beat(8)3
Avg EPS beat(8)-157.68%
EPS beat(12)6
Avg EPS beat(12)-29.95%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.01%
Min Revenue beat(2)-7.48%
Max Revenue beat(2)-6.54%
Revenue beat(4)0
Avg Revenue beat(4)-4.52%
Min Revenue beat(4)-7.48%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-2.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)8
Avg Revenue beat(16)0.13%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-3.69%
Revenue NY rev (3m)-3.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.16
P/FCF 27.36
P/OCF 16.41
P/B 3.2
P/tB 18.86
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)0.3
FCFY3.66%
OCF(TTM)0.5
OCFY6.09%
SpS3.82
BVpS2.58
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.15%
ROE -15.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.5%
FCFM 7.89%
ROA(3y)-0.03%
ROA(5y)-2%
ROE(3y)0.16%
ROE(5y)-27.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y-3.79%
F-Score5
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.16
Debt/EBITDA N/A
Cap/Depr 68.63%
Cap/Sales 5.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.95
Altman-Z 2.9
F-Score5
WACC11.16%
ROIC/WACCN/A
Cap/Depr(3y)67.37%
Cap/Depr(5y)74.13%
Cap/Sales(3y)3.99%
Cap/Sales(5y)3.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-290%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.11%
EPS Next Y-325%
EPS Next 2Y-57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.7%
Revenue growth 3Y16.28%
Revenue growth 5Y48.02%
Sales Q2Q%-12.82%
Revenue Next Year-8.55%
Revenue Next 2Y2.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-326.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.78%
FCF growth 3Y55.92%
FCF growth 5YN/A
OCF growth 1Y39.3%
OCF growth 3Y40.54%
OCF growth 5YN/A

INTELLINETICS INC / INLX FAQ

What is the ChartMill fundamental rating of INTELLINETICS INC (INLX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to INLX.


What is the valuation status of INTELLINETICS INC (INLX) stock?

ChartMill assigns a valuation rating of 1 / 10 to INTELLINETICS INC (INLX). This can be considered as Overvalued.


What is the profitability of INLX stock?

INTELLINETICS INC (INLX) has a profitability rating of 2 / 10.


How financially healthy is INTELLINETICS INC?

The financial health rating of INTELLINETICS INC (INLX) is 4 / 10.


Can you provide the expected EPS growth for INLX stock?

The Earnings per Share (EPS) of INTELLINETICS INC (INLX) is expected to decline by -325% in the next year.